Indeed, vaccination of mice with IDO-silenced DC confers partial protection against B16 melanoma (142), and a recent case report has revealed immunologic and clinical benefits of an IDO-silenced DC vaccine in a melanoma patient (143). This evidence concerns the gene IDO1 and melanoma.